Hospital Taiping
Taiping 34000
2 studies enrolling now · 13 studies all time
What they study most
Atrial Fibrillation, Diabetes Mellitus, Diabetes Mellitus, Type 2, Gastroparesis, Influenza A, Kidney Disease, Chronic, Lupus Erythematosus, Systemic, Metapneumovirus, Respiratory Tract Infections
Studies at this site
- A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus — Recruiting now
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
- A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) — Stopped early
- A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection — Stopped early
- A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 — Stopped early
- Diabetic Gastroparesis Study 05 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 — Stopped early
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
- Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus — Withdrawn before enrolling